Who is sponsoring NCT01183585?

NCT01183585 is sponsored by Hoffmann-La Roche.

What condition does NCT01183585 study?

NCT01183585 studies Healthy Volunteer.

What drugs are being tested in NCT01183585?

Interventions: RO4917838 and Rosuvastatin.

What is the status of NCT01183585?

NCT01183585 is currently COMPLETED.

Last reviewed 2016-11-01 · How we verify

A Single Center, Open-label, Fixed Sequence, Two-period Study to Investigate the Effect of RO4917838 on the Pharmacokinetics of Rosuvastatin in Healthy Volunteers

NCT01183585 Phase 1 COMPLETED

This single centre, open-label study will investigate the effect of RO4917838 on the pharmacokinetics of Rosuvastatin, a frequently co-prescribed drug in healthy volunteers. Healthy volunteers will receive multiple oral doses of RO4917838 and single oral dose of Rosuvastatin.

Details

Lead sponsor	Hoffmann-La Roche
Phase	Phase 1
Status	COMPLETED
Enrolment	18
Start date	2010-08
Completion	2010-09

Conditions

Healthy Volunteer

Interventions

RO4917838 and Rosuvastatin

Primary outcomes

To determine the effect of multiple doses of RO4917838 on single-dose pharmacokinetics of Rosuvastatin — 30 days

Countries

France